Abbott Unit's Injunction Bid Denied In Stent Spat
A federal judge denied a permanent injunction bid from an Abbot Laboratories subsidiary that took aim at Medtronic Inc.'s Endeavor drug-eluting stent, the latest development in a long-running battle over stent...To view the full article, register now.
Already a subscriber? Click here to view full article